IT1272149B - Composizione farmeceutiche ad attivita' analgesica - Google Patents

Composizione farmeceutiche ad attivita' analgesica

Info

Publication number
IT1272149B
IT1272149B ITMI930582A ITMI930582A IT1272149B IT 1272149 B IT1272149 B IT 1272149B IT MI930582 A ITMI930582 A IT MI930582A IT MI930582 A ITMI930582 A IT MI930582A IT 1272149 B IT1272149 B IT 1272149B
Authority
IT
Italy
Prior art keywords
analgesic activity
pharmeceutical
composition
pharmeceutical composition
propionic
Prior art date
Application number
ITMI930582A
Other languages
English (en)
Inventor
Federico Stroppolo
Daniele Bonadeo
Luigi Vigano
Annibale Gazzaniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of ITMI930582A0 publication Critical patent/ITMI930582A0/it
Priority to ITMI930582A priority Critical patent/IT1272149B/it
Priority to CH71194A priority patent/CH686403A5/it
Priority to FR9402977A priority patent/FR2703249B1/fr
Priority to BE9400290A priority patent/BE1006718A3/fr
Priority to GB9405420A priority patent/GB2276545B/en
Priority to SE9401005A priority patent/SE517006C2/sv
Priority to DE4410470A priority patent/DE4410470A1/de
Priority to CA002120048A priority patent/CA2120048C/en
Priority to ES09400644A priority patent/ES2109131B1/es
Priority to JP05571694A priority patent/JP3784843B2/ja
Priority to NL9400481A priority patent/NL194390C/nl
Publication of ITMI930582A1 publication Critical patent/ITMI930582A1/it
Priority to US08/470,143 priority patent/US5693312A/en
Application granted granted Critical
Publication of IT1272149B publication Critical patent/IT1272149B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Vengono descritte composizioni farmaceutiche ad attività analgesica contenenti acido (S)-2-(6-metossi-2-naftil)-propionico come principio attivo ed arginina, utili per la preparazione di forme farmaceutiche per uso orale.
ITMI930582A 1993-03-26 1993-03-26 Composizione farmeceutiche ad attivita' analgesica IT1272149B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI930582A IT1272149B (it) 1993-03-26 1993-03-26 Composizione farmeceutiche ad attivita' analgesica
CH71194A CH686403A5 (it) 1993-03-26 1994-03-10 Composizione farmaceutica ad attivita analgesica contenente Naproxen e arginina.
FR9402977A FR2703249B1 (fr) 1993-03-26 1994-03-15 Composition pharmaceutique ayant une activité analgésique contenant du naproxène.
BE9400290A BE1006718A3 (fr) 1993-03-26 1994-03-17 Composition pharmaceutique ayant une activite analgesique contenant du naproxene.
GB9405420A GB2276545B (en) 1993-03-26 1994-03-18 Pharmaceutical compositions having analgesic activity
DE4410470A DE4410470A1 (de) 1993-03-26 1994-03-25 Pharmazeutische Zusammensetzungen mit analgetischer Aktivität
SE9401005A SE517006C2 (sv) 1993-03-26 1994-03-25 Farmaceutisk komposition med förbättrad analgetisk aktivitet innehållande (S)-2-(6-metoxi-2-naftyl)propionsyra (naproxen) och arginin
CA002120048A CA2120048C (en) 1993-03-26 1994-03-25 Pharmaceutical composition having analgesic activity
ES09400644A ES2109131B1 (es) 1993-03-26 1994-03-25 Composicion farmaceutica que tiene actividad analgesica.
JP05571694A JP3784843B2 (ja) 1993-03-26 1994-03-25 鎮痛作用を有する薬剤組成物
NL9400481A NL194390C (nl) 1993-03-26 1994-03-25 Farmaceutische samenstelling die analgetische activiteit bezit met (s)- 2-(6-methoxy-2-naftyl)propionzuur en arginine.
US08/470,143 US5693312A (en) 1993-03-26 1995-06-06 Pharmaceutical composition having analgesic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930582A IT1272149B (it) 1993-03-26 1993-03-26 Composizione farmeceutiche ad attivita' analgesica

Publications (3)

Publication Number Publication Date
ITMI930582A0 ITMI930582A0 (it) 1993-03-26
ITMI930582A1 ITMI930582A1 (it) 1994-09-26
IT1272149B true IT1272149B (it) 1997-06-11

Family

ID=11365508

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930582A IT1272149B (it) 1993-03-26 1993-03-26 Composizione farmeceutiche ad attivita' analgesica

Country Status (12)

Country Link
US (1) US5693312A (it)
JP (1) JP3784843B2 (it)
BE (1) BE1006718A3 (it)
CA (1) CA2120048C (it)
CH (1) CH686403A5 (it)
DE (1) DE4410470A1 (it)
ES (1) ES2109131B1 (it)
FR (1) FR2703249B1 (it)
GB (1) GB2276545B (it)
IT (1) IT1272149B (it)
NL (1) NL194390C (it)
SE (1) SE517006C2 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
GB9924636D0 (en) * 1999-10-18 1999-12-22 Norgine Bv Laxative preparation
US20030235629A1 (en) * 1999-11-06 2003-12-25 Janmarie Hornack Dietary supplement containing alkaline electrolyte buffers
JP5185488B2 (ja) * 2001-11-02 2013-04-17 カンバーランド ファーマシューティカルズ，インコーポレーテッド ２−（４−イソブチルフェニル）プロピオン酸の医薬組成物
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
WO2004089365A1 (en) * 2003-04-11 2004-10-21 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
ATE489077T1 (de) 2006-09-28 2010-12-15 Losan Pharma Gmbh Schnell lösliche formulierung von nichtsteroidalen antiphlogistika
EP2155214A1 (en) * 2007-05-22 2010-02-24 Glenn Abrahmsohn Method for pain control
US8828452B2 (en) * 2007-05-22 2014-09-09 Glenn Abrahmsohn Method for pain control
BRPI0800951A2 (pt) * 2008-04-09 2012-02-22 Ems Sa novos compostos derivados de taurina e seus usos, processo de sua preparação e composições farmacêuticas contendo os mesmos
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
JP7163014B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 感冒薬
US11779541B2 (en) 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904682A (en) * 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4344929A (en) * 1980-04-25 1982-08-17 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4587249A (en) * 1982-07-22 1986-05-06 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
SE463541B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
KR920700613A (ko) * 1989-05-16 1992-08-10 지구르트 퓌터 약제제
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars

Also Published As

Publication number Publication date
GB9405420D0 (en) 1994-05-04
NL194390C (nl) 2002-03-04
ITMI930582A0 (it) 1993-03-26
BE1006718A3 (fr) 1994-11-22
GB2276545B (en) 1996-08-14
NL194390B (nl) 2001-11-01
US5693312A (en) 1997-12-02
FR2703249B1 (fr) 1995-07-13
SE517006C2 (sv) 2002-04-02
DE4410470A1 (de) 1994-09-29
SE9401005L (sv) 1994-09-27
SE9401005D0 (sv) 1994-03-25
JPH06321777A (ja) 1994-11-22
NL9400481A (nl) 1994-10-17
GB2276545A (en) 1994-10-05
CA2120048A1 (en) 1994-09-27
ES2109131A1 (es) 1998-01-01
ES2109131B1 (es) 1998-08-16
JP3784843B2 (ja) 2006-06-14
FR2703249A1 (fr) 1994-10-07
CA2120048C (en) 2004-01-27
ITMI930582A1 (it) 1994-09-26
CH686403A5 (it) 1996-03-29

Similar Documents

Publication Publication Date Title
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
IT1190727B (it) Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
RU94041836A (ru) Производные амидина, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция с антагонистической в отношении лейкотриена в*004 активностью
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
IT1226549B (it) Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
ITMI931326A1 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
ITMI930582A1 (it) Composizione farmeceutiche ad attivita' analgesica
ITMI941262A0 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
IT8619284A0 (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico.
ATE286395T1 (de) Antithrombotische mittel
IT1184139B (it) Composti ad attivita' mucolitica e broncodilatatrice,procedimento per la loro preparazione e composizioni farmaceutiche che licontengono come principi attivi
IT9021240A0 (it) Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche
ITMI912238A0 (it) Composti ad attivita' mucolitica e antisettica procedimento per la loro preparazione e relative composizioni farmaceutiche
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
IT8521801A0 (it) 1,4-diamino-butano, suoi derivati mano-e diacilati, che posseggono attivita' analgesica, antiinfiammatoria ed antipiretica; metodi di preparazione e forme farmaceutiche che li contengono come principi attivi.
IT8219215A0 (it) Composto ad attivita' analgesica, antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
IT8519975A0 (it) Composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
ITMI922216A1 (it) Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono
IT8519205A0 (it) Sali di calcio ad attivita'mucolitica e broncodilatatrice; procedimento per la loro preparazione e composizioni farmaceutiche che li contengono come principi attivi.
IT8522275A0 (it) Uso farmaceutico dellhacido (1-fenilmetil-5-idrossi-1h-indazol3-il)-ossiacetico e dei suoi sali di addizione basica farmaceuticamente accettabili, composizioni farmaceutiche che licontengono.
IT8521917A0 (it) Composti ad attivita' antispastica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono come principi attivi.
IT8219456A0 (it) Composto ad attivita'analgesica e antiinfiammatoria ad azione protratta, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971020